Atul Ltd - 500027 - Letter Attached
Atul Ltd has approved a capital expenditure of Rs.167 crore for a new manufacturing facility. This expansion will add 1,000 tpa of Mecoprop-p (MCPP-p) and 750 tpa of 2-methyl-4-chlorophenoxyacetic acid (MCPA) capacity, funded via internal accruals.
Jul 24 2026 14:35:11
Atul Ltd - 500027 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund acquired 10,140 shares of Atul Ltd on July 17, 2026, increasing its total shareholding to 5.004%. This transaction was conducted via open market purchase and triggered a SAST disclosure as the stake crossed the 5% threshold.
Jul 20 2026 19:37:45
Atul Ltd - 500027 - Announcement under Regulation 30 (LODR)-Change in Management
Atul announced the appointment of Mr. Dhaval Vashi as Senior Vice President, Pharmaceuticals, and Mr. Vinay Desai as Executive Vice President, Technology and Manufacturing. Both appointments are effective from July 18, 2026, strengthening the company's senior management team.
Jul 20 2026 17:27:08
Atul Ltd - 500027 - Board Meeting Intimation for Financial Results For The First Quarter Ending On June 30, 2026.
Atul's Board of Directors is scheduled to meet on July 24, 2026, to consider and approve the financial results for the first quarter of FY27, ending June 30, 2026. This meeting is a key step towards announcing the company's latest performance metrics.
Jun 25 2026 16:41:44
Read More